[Ip-health] UC Berkeley & Columbia: Role of Universities & Access to Medicines

[Caroline Gallant]

--
[ Picked text/plain from multipart/alternative ]
OUR LABS. OUR DRUGS. OUR RESPONSIBILITY.

APRIL 18TH: Universities Allied for Essential Medicine=92s National Day
of Action unites students at over 50 universities in the US, UK and
Canada to call on universities to recognize their role in the global
access to medicines crisis and their responsibility to bring about
change.

We would like to highlight two events occurring at UC Berkeley (Monday,
April 16th) and Columbia University (Tuesday, April 17th) leading up to
the National Day of Action.

More information on the events occurring on April 18th will be
forthcoming.

For a full list of events and more information, please visit:
www.essentialmedicine.org/action

--

University of California, BERKELEY Hosts Conference to Address Access
to University Developed Medicines

As part of Universities Allied for Essential Medicines (UAEM) National
Day of Action, UC Berkeley has convened leading researchers to discuss
speeding access to drugs and technologies discovered in university
labs.  Former Rwandan ambassador to the United States and visiting
scholar Theogene Rudasingwa will give a keynote lecture on the subject
to be followed by a panel of distinguished scientists including
professors Jay Keasling and James McKerrow (UCSF) and Dean of
Biological Sciences Geoffrey Owen. The panel will be moderated by Tom
Kalil, special assistant to the chancellor for science and technology.

     Date:=09Monday, April 16, 2007
     Time:=096:30-8:30pm
     Location:=09West Pauley Ballroom, MLK Student Union, UC Berkeley

For further information: Basit Khan abkhan@berkeley.edu 559-313-4699

--

**Tuesday, April 17th, 7:30 PM***
COLUMBIA University, Fayerweather 310, Morningside Campus

Intellectual Property and Access to Essential Medicines: The Impact on
Global Health

Global Justice and Universities Allied for Essential Medicines are
  hosting a panel discussion on the interrelation between intellectual
property, patents, and access to essential medicines.=A0=A0The panel will
consist of three distinguished speakers from different disciplines:

Thomas Pogge, Professor of Philosophy. His philosophical work has
recently been on issues of global justice, and on the existence of
extreme poverty as a human rights violation.=A0=A0He has also looked at
issues of justice in healthcare, examining how the benefits of
pharmaceutical innovation can be better distributed to the world's
poor. He is currently working on solutions to this ethical problem, one
of which is a special type of patent.=A0

Dr. David Hoos, Professor of Clinical Epidemiology, Mailman School of
Public Health.=A0=A0Dr. Hoos is the coordinator at MSPH for the Fogarty
International Center of the NIH funded Columbia University =96 Southern
Africa AIDS International Training and Research Program. In addition,
Dr. Hoos is a member of the MTCT Plus Secretariat at MSPH, with
responsibility for drug procurement for this international HIV/AIDS
treatment program. He is responsible also for several other new
international training and technical assistance initiatives at MSPH
primarily in HIV/AIDS related areas. Dr. Hoos is also involved in a
HIV seroprevalence study of acute psychiatric patients in KwaZulu
Natal, South Africa.=A0=A0Dr. Hoos is also serving on a number of
international panels related to scale up of international HIV/AID
treatment, including the Procurement Advisory Group to the Global Fund
for AIDS, TB and Malaria, and the HIV/AIDS workgroup for the UN
Millenium Development Goals.

Bhaven Sampat, Professor at the Mailman School of Public Health:=A0=A0Dr.
Sampat's research centers on the economics of biomedical innovation,
the law and economics of the patent system, and science policy. His
current projects examine the political economy of the National
Institutes of Health, the effects of patents on access to medicines in
India, the interactions between patent laws and FDA regulation in the
pharmaceutical industry, the determinants of patent quality in the
U.S. patent system, and challenges to evidence--based medicine in
contexts of rapid technological change.

Please join us for the panel and the following Question and Answer
session.
Refreshments will be served. Please join us! email kjc2106@columbia.edu
for more info.
--